Format

Send to

Choose Destination
Contraception. 2006 Aug;74(2):104-9. Epub 2006 Jun 16.

Pharmacokinetics of single-dose levonorgestrel in adolescents.

Author information

1
Department of Biopharmaceutical Sciences, School of Pharmacy, University of California San Francisco, Box 0446, San Francisco, CA 94143-0446, USA. nancy.sambol@ucsf.edu

Abstract

PURPOSE:

The purpose of this study is to compare the pharmacokinetics of levonorgestrel, a drug used for emergency contraception between female adolescents and adults.

METHODS:

Twenty-two female subjects, aged 13-16 years, received a single 0.75-mg dose of the drug. Serial blood samples were collected for 72 h and used to measure plasma levonorgestrel concentrations. Previously published data from 16 adults, aged 18-45 years, served as comparison.

RESULTS:

There was a statistically significant higher total plasma clearance divided by the bioavailability (CL/F) of levonorgestrel in adolescents compared to adults, resulting in lower maximum and average total plasma concentrations. There was a trend for a larger volume of distribution divided by bioavailability (V/F), but there was no significant difference in the half-life of levonorgestrel in adolescents relative to adults (p=.098).

CONCLUSION:

The differences between adolescents and adults are unlikely to be clinically significant because specific changes in total concentrations suggest that unbound concentrations are probably not affected. Furthermore, empirically high doses of levonorgestrel are given for emergency contraception.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center